Skip to main content

Thoracic Oncology

Featured Article
A recent study sought to understand the impact of costs incurred through hospitalization after resection among lung cancer patients.
Recent research, reported in The New England Journal of Medicine, showed that Tagrisso improved outcomes among non-small cell lung cancer (NSCLC) patients with an epidermal growth factor receptor.
Back to Top